Literature DB >> 1828171

Neuroendocrine activity in untreated heart failure.

J Remes1, I Tikkanen, F Fyhrquist, K Pyörälä.   

Abstract

Neuroendocrine activity was studied in 60 consecutive untreated patients with dyspnoea and a clinical suspicion of heart failure. On the basis of the so-called Boston clinical criteria the diagnosis of heart failure was regarded as unlikely in 26 patients, possible in 15 patients, and definite in 19 patients. These groups were studied before any drug treatment was started and were compared with a control group of 69 healthy individuals. Plasma atrial natriuretic peptide concentration was clearly raised in patients with definite heart failure and slightly raised in patients with possible heart failure. Plasma adrenaline concentration was somewhat raised in patients with definite or possible heart failure, whereas plasma noradrenaline concentration was raised only in patients with definite heart failure. Plasma renin activity was not increased in any of the patient groups and plasma aldosterone concentration was slightly increased only in patients with definite heart failure. In the total patient series there were significant correlations between plasma atrial natriuretic peptide concentration and markers of the severity of left ventricular dysfunction. There was some evidence of neuroendocrine activation in untreated heart failure: plasma concentrations of atrial natriuretic peptide and catecholamines were increased but the renin-angiotensin-aldosterone system showed little or no activation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1828171      PMCID: PMC1024625          DOI: 10.1136/hrt.65.5.249

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  28 in total

1.  Neuroendocrine response in acute heart failure and the influence of treatment.

Authors:  M Broqvist; U Dahlström; B E Karlberg; E Karlsson; T Marklund
Journal:  Eur Heart J       Date:  1989-12       Impact factor: 29.983

2.  Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III).

Authors:  M S Hirsch; G P Wormser; R T Schooley; D D Ho; D Felsenstein; C C Hopkins; C Joline; F Duncanson; M G Sarngadharan; C Saxinger
Journal:  N Engl J Med       Date:  1985-01-03       Impact factor: 91.245

3.  Release of atrial natriuretic peptide-like immunoreactive material during stretching of the rat atrium in vitro.

Authors:  G Agnoletti; A Rodella; R Ferrari; P Harris
Journal:  J Mol Cell Cardiol       Date:  1987-03       Impact factor: 5.000

4.  Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effect of upright posture and diuretics.

Authors:  S H Kubo; M Clark; J H Laragh; J S Borer; R J Cody
Journal:  Am J Cardiol       Date:  1987-12-01       Impact factor: 2.778

5.  Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure.

Authors:  I S Anand; R Ferrari; G S Kalra; P L Wahi; P A Poole-Wilson; P C Harris
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

6.  Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

Authors:  J Bayliss; M Norell; R Canepa-Anson; G Sutton; P Poole-Wilson
Journal:  Br Heart J       Date:  1987-01

7.  Atrial natriuretic factor in rat hypothalamus, atria and plasma: determination by specific radioimmunoassay.

Authors:  I Tanaka; K S Misono; T Inagami
Journal:  Biochem Biophys Res Commun       Date:  1984-10-30       Impact factor: 3.575

8.  Atrial natriuretic factor--a circulating hormone stimulated by volume loading.

Authors:  R E Lang; H Thölken; D Ganten; F C Luft; H Ruskoaho; T Unger
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

9.  Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy.

Authors:  H Yasue; K Obata; K Okumura; M Kurose; H Ogawa; K Matsuyama; M Jougasaki; Y Saito; K Nakao; H Imura
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

10.  Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure.

Authors:  A E Raine; P Erne; E Bürgisser; F B Müller; P Bolli; F Burkart; F R Bühler
Journal:  N Engl J Med       Date:  1986-08-28       Impact factor: 91.245

View more
  9 in total

Review 1.  Neuroendocrine activation after myocardial infarction: causes and consequences.

Authors:  J G Cleland; P J Cowburn; K Morgan
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 2.  Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure.

Authors:  J Feenstra; D E Grobbee; A Mosterd; B H Stricker
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

Review 3.  Results of clinical trials with diuretics in heart failure.

Authors:  J R Hampton
Journal:  Br Heart J       Date:  1994-08

Review 4.  Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure?

Authors:  A Sigurdsson; K Swedberg
Journal:  Br Heart J       Date:  1994-09

Review 5.  Neuroendocrine activation after myocardial infarction.

Authors:  J Remes
Journal:  Br Heart J       Date:  1994-09

6.  Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation.

Authors:  Ken Shimamoto; Miyako Kusumoto; Rieko Sakai; Hirota Watanabe; Syunichi Ihara; Natsuka Koike; Masatoshi Kawana
Journal:  Can J Cardiol       Date:  2007-03-15       Impact factor: 5.223

Review 7.  Vasopeptidase inhibitors: will they have a role in clinical practice?

Authors:  Matthew I Worthley; Roberto Corti; Stephen G Worthley
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

8.  Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.

Authors:  A Sigurdsson; O Amtorp; T Gundersen; B Nilsson; J Remes; K Swedberg
Journal:  Br Heart J       Date:  1994-11

Review 9.  Postinfarct heart failure: role of diuretic therapy.

Authors:  J R Hampton
Journal:  Cardiovasc Drugs Ther       Date:  1993-12       Impact factor: 3.727

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.